| Nov 14 |
AEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment Measures
|
| Nov 14 |
Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally
|
| Nov 14 |
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ...
|
| Nov 14 |
Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript
|
| Nov 13 |
Aethlon Medical GAAP EPS of -$0.20 in-line
|
| Nov 13 |
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
|
| Nov 13 |
Earnings Scheduled For November 13, 2024
|
| Nov 12 |
Aethlon Medical Q2 2025 Earnings Preview
|
| Nov 12 |
Innovative Medical Technology Advances with First Patient Enrollments
|
| Nov 11 |
Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer
|
